导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -22.75% | 1020/1050 |
| 近一周 | -4.71% | 1047/1104 |
| 近一月 | -13.37% | 1096/1102 |
| 近一季 | -25.15% | 1054/1092 |
| 近半年 | -28.63% | 1055/1070 |
| 近一年 | -9.66% | 744/1018 |
| 近两年 | 79.10% | 293/926 |
| 近三年 | 17.93% | 516/834 |
| 成立以来 | 190.95% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.74% 212/1070 |
-2.88% 753/1101 |
- - |
- - |
| 2025 | 62.86% 91/1065 |
4.64% 435/1014 |
0.34% 658/1038 |
52.21% 74/1050 |
1.91% 316/1065 |
| 2024 | -0.04% 582/1011 |
-12.04% 827/960 |
-10.72% 887/983 |
19.35% 74/991 |
6.66% 100/1011 |
| 2023 | -29.09% 799/952 |
-4.02% 770/880 |
-6.74% 626/895 |
-16.10% 802/915 |
-5.58% 565/952 |
| 2022 | -33.70% 692/867 |
-17.45% 391/773 |
12.48% 176/806 |
-22.79% 782/845 |
-7.52% 724/867 |
| 2021 | 26.09% 104/740 |
-8.95% 468/580 |
26.77% 67/659 |
7.95% 85/704 |
1.19% 389/740 |
| 2020 | 106.98% 20/554 |
0.85% 141/419 |
31.66% 102/466 |
15.69% 135/517 |
34.74% 27/554 |
| 2019 | 61.32% 73/410 |
29.94% 382/1146 |
-3.90% 640/1228 |
13.76% 59/390 |
13.57% 82/410 |
| 2018 | -27.79% 189/349 |
- - |
-15.85% 799/990 |
-8.30% 670/1000 |
-1.21% 14/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实新能源新材料股票C VS. 东吴新产业精选股票A(580008) |